Indaptus Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Indaptus Therapeutics (INDP) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Indaptus Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Indaptus Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Indaptus Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $2.1k | 2.5k | 0.84 |
2024-09-30 | $647 | 522 | 1.24 |
2024-06-30 | $1.5k | 692 | 2.12 |
2024-03-31 | $4.3k | 1.9k | 2.24 |
2023-12-31 | $6.5k | 3.7k | 1.76 |
2023-09-30 | $376 | 137 | 2.75 |
2023-06-30 | $1.2k | 640 | 1.91 |
2022-03-31 | $13k | 3.3k | 3.95 |
2021-12-31 | $28k | 4.9k | 5.68 |
2021-09-30 | $1.0k | 132 | 7.58 |